Back to Directory
iuvantium
South East England
Founded 2022
Inorganic nanoscale immune modulators for infection, cancer and autoimmunity
Iuvantium is a biotechnology company developing therapeutics and vaccines based on inorganic nanoscale materials that modulate the immune system.
The company uses tailored inorganic probes to study how the immune system responds, builds a computational model of immune behaviour, and designs programmable immune modulators for manufacture in house.
Its work focuses on infectious disease, including antimicrobial resistance, as well as oncology and autoimmune disease.